electroCore (ECOR) EBT Margin Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -300.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -287.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 233.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 772.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -464.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 584.00 |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn | -26.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.00 |
| Dec 31, 2025 | -14,521.00 |
| Sep 30, 2025 | -109.00 |
| Jun 30, 2025 | -649.00 |
| Mar 31, 2025 | 857.00 |
| Dec 31, 2024 | 18,679.00 |
| Sep 30, 2024 | 5,134.00 |
| Jun 30, 2024 | 9,483.00 |
| Mar 31, 2024 | 15,198.00 |
| Dec 31, 2023 | 11,236.00 |
| Sep 30, 2023 | 18,652.00 |
| Jun 30, 2023 | 12,998.00 |
| Mar 31, 2023 | 7,531.00 |
| Dec 31, 2022 | -97,223.00 |
| Sep 30, 2022 | -797.00 |
| Jun 30, 2022 | 2,974.00 |
| Mar 31, 2022 | 15,323.00 |
| Dec 31, 2021 | 146,984.00 |
| Sep 30, 2021 | 14,710.00 |
| Jun 30, 2021 | 48,744.00 |
| Mar 31, 2021 | 63,754.00 |
| Dec 31, 2020 | 57,522.00 |
| Sep 30, 2020 | 114,975.00 |
| Jun 30, 2020 | 115,787.00 |
| Mar 31, 2020 | 229,944.00 |
| Dec 31, 2019 | 291,090.00 |
| Sep 30, 2019 | 717,950.00 |
| Jun 30, 2019 | 257,901.00 |
| Mar 31, 2019 | 824,768.00 |
| Dec 31, 2018 | -171,621.00 |
| Sep 30, 2018 | -437,609.00 |
| Jun 30, 2018 | -32,439.00 |